Novo co-led a second tranche that lifted Metagenomi’s series B round to $275m while crypto payment technology provider Wyre is shutting after a $1.5bn acquisition fell through.



Pharmaceutical firm Moderna has agreed to pay $85m to acquire OriCiro Genomics, a Japan-based developer of cell-free synthesis technology, allowing trading group Itochu and pharmaceutical company Asahi Kasei to exit. Coprorate venturing unit Itochu Technology Ventures took part in a $7.3m series B round in mid-2021 that increased the total raised by OriCiro to $10.9m, before Ashai Kahei added an undisclosed sum in June…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.